Pacific Bio (PACB) Tops Q1 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $38.9 million versus the consensus estimate of $34.38 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• United Community Banks sells equipment finance unit for $1.9 billion
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00